AI-powered GI disorder management with advanced endoscopy analysis
Advanced endoscopy analysis and digestive health insights
SynThera revolutionizes gastroenterology practice through intelligent endoscopy analysis, automated polyp detection, and comprehensive digestive health assessment. Our AI provides real-time insights for IBD monitoring, liver disease evaluation, and early cancer detection.
Endoscopic imaging analysis with AI detection
Real-time detection and classification of colorectal polyps with size estimation, morphology assessment, and histology prediction using advanced computer vision.
Automated calculation of endoscopic activity scores for IBD including Mayo Score, SES-CD, and UCEIS with standardized documentation.
Intelligent identification of Barrett's esophagus with dysplasia assessment and Prague classification for surveillance optimization.
Automated analysis of capsule endoscopy images for small bowel lesion detection, bleeding source identification, and transit time assessment.
AI-powered analysis of ultrasound, CT, and MRI for hepatic lesion characterization, fibrosis assessment, and portal flow evaluation.
Automated monitoring of procedure quality metrics including withdrawal time, adenoma detection rate, and bowel preparation adequacy.
Polyp detection accuracy
Reduction in missed adenomas
IBD activity score correlation
Time saved in reporting
During a routine colonoscopy for a 58-year-old patient, SynThera's AI identifies a 12mm polyp in the ascending colon, classifies it as a tubular adenoma with high-grade dysplasia, and recommends immediate polypectomy with histological confirmation.
AI Insight:
"12mm sessile polyp, Paris classification 0-Is. Pit pattern III-L suggests tubular adenoma. Recommend EMR technique with submucosal injection for complete resection."
A 32-year-old Crohn's patient undergoes surveillance colonoscopy. SynThera analyzes endoscopic images, calculates SES-CD score of 8, identifies active inflammation in the terminal ileum, and suggests treatment escalation.
AI Insight:
"SES-CD: 8 (moderate activity). Deep ulcerations in terminal ileum with mucosal edema. Consider anti-TNF therapy optimization or switch to different MOA."
A 65-year-old patient with known Barrett's esophagus undergoes surveillance EGD. SynThera detects subtle mucosal changes consistent with low-grade dysplasia and recommends targeted biopsies using advanced imaging techniques.
AI Insight:
"C3M5 Barrett's with irregular mucosal pattern at Z-line. NBI enhancement suggests LGD. Recommend Seattle protocol biopsies plus targeted sampling of irregular areas."
Advanced colorectal cancer screening with real-time polyp detection, size measurement, and histology prediction.
AI assistance for therapeutic procedures including ESD, ERCP, and EUS-guided interventions.
Integration with molecular testing for personalized therapy selection in IBD and gastrointestinal cancers.
Population-level analytics for screening program optimization and quality improvement initiatives.
Join leading gastroenterologists who are leveraging SynThera's AI to enhance polyp detection, optimize IBD management, and improve patient outcomes across all GI subspecialties.